Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDiscoverIE Regulatory News (DSCV)

Share Price Information for DiscoverIE (DSCV)

Share Price is delayed by 15 minutes
Get Live Data
709.00    2.00 (0.28%)
Bid:
708.00
Ask:
710.00
Spread: 2.00 (0.282%)
Market Cap: £688.59m
DSCV Live PriceLast checked at - London Stock Exchange

Intraday DiscoverIE Share Chart

Acquisition

12 Jan 2011 07:00

RNS Number : 3039Z
Acal PLC
12 January 2011
Β 

ο»Ώ

For Release

7.00am, 12 January 2011

Β 

Acal plc

Β 

Acal Strengthens Electronics Division with the Acquisition of

a German Specialist Electronics business

Β 

Acal plc (LSE: ACL, "The Group"), the pan European specialist provider of technology services, is pleased to announce the acquisition of 100% of CompoTRON GmbH ("CompoTRON"), for a maximum consideration of Β£7.1m (€8.5m) before expenses. CompoTRON has been acquired from BW-Holding GmbH, a company wholly owned by the CompoTRON management, Mr W Brack and Ms B Lohmaier.

CompoTRON is a specialist provider of electronic communication and fibre optic components to the European industrial electronic markets. Based in Munich with operations in Germany, the UK and Denmark, CompoTRON employs 22 staff. The company will form a separate business unit within Acal's Electronics division and will retain its strong independent brand identity.

Β 

The initial cash consideration of €6.8m (Β£5.7m) will be paid from the Group's existing cash resources. Additional deferred cash consideration of up to €1.7m (Β£1.4m) will be payable in January 2013 subject to the business achieving agreed performance targets over the next two years. Mr W Brack and Ms B Lohmaier will remain with the business and have committed to purchase 61,450 new ordinary shares in Acal plc at 270.5 pence per share, the average mid market closing price for the 5 days up to and including 10 January 2011.

Β 

CompoTRON's revenues for the year ended 31 December 2009 were €7.3m (Β£6.1m) and it generated a pre tax profit of €1.0m (Β£0.8m). Gross assets at 31 December 2009 were €2.2m (Β£1.8m). Forecast revenues for the year ended 31 December 2010 are approximately €10m (Β£8.3m), 37% ahead of the previous year. The acquisition is expected to be earnings enhancing on an underlying profits basis for the Group's year ended 31 March 2011.

Β 

Nick Jefferies, Chief Executive of Acal plc said:

Β 

"The acquisition of CompoTRON is a further step in the implementation of our European specialisation strategy, enhancing our position in the German specialist electronics market. It follows the acquisition of BFi Optilas in December 2009 which has now been successfully integrated into Acal. We are delighted to welcome CompoTRON into the Group."

For further information please contact:

Acal plc

Nick Jefferies - Group Chief Executive

Simon Gibbins - Group Finance Director

Β 

Cubitt Consulting

Chris Lane/Samantha Boston

01483 544500

Β 

Β 

Β 

020 7367 5100

Β 

Notes to Editors:

Β 

About Acal plc

The Acal Group is a leading technology-based specialist distributor in Europe providing sales, marketing and other services through three divisions: Electronics, Supply Chain and Medical. The Electronics Division distributes electronic and photonic products to industrial manufacturing and design companies. The Supply Chain Division supplies new and refurbished IT and EPOS spare parts to service providers while the Medical Division supplies advanced medical equipment to public and private healthcare providers. Acal has operating companies in the UK, Netherlands, Belgium, Germany, France, Italy, South Africa, Spain and the Nordic region.

Β 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
ACQEANFFFLSFEFF
Date   Source Headline
27th Mar 20182:41 pmRNSHolding(s) in Company
15th Mar 20187:00 amRNSNotice of Capital Markets Day
5th Mar 201810:26 amRNSDirector/PDMR Shareholding
21st Feb 20189:15 amRNSIssue of Equity
9th Feb 201812:11 pmRNSDirector/PDMR Shareholding
2nd Feb 20182:48 pmRNSTotal Voting Rights
1st Feb 20187:00 amRNSAcquisition
31st Jan 20187:00 amRNSTrading Update
23rd Jan 20187:00 amRNSDirectorate Change
29th Nov 20178:01 amRNSChange of Name
28th Nov 20179:06 amRNSHolding(s) in Company
28th Nov 20177:01 amRNSChange of Name
28th Nov 20177:00 amRNSHalf-year Report
16th Oct 20177:00 amRNSTrading Update
11th Oct 20175:25 pmRNSHolding(s) in Company
19th Sep 20175:04 pmRNSHolding(s) in Company
14th Sep 20177:00 amRNSSector Reclassification
13th Sep 201710:36 amRNSNotification of Change of Auditor
17th Aug 20172:33 pmRNSHolding(s) in Company
15th Aug 201711:32 amRNSDirector/PDMR Shareholding
4th Aug 201710:00 amRNSEXERCISE OF SHARE OPTION
3rd Aug 20174:30 pmRNSHolding(s) in Company
25th Jul 20173:47 pmRNSResult of AGM
25th Jul 20177:00 amRNSTrading Update
26th Jun 201710:38 amRNSAnnual Report and Accounts
21st Jun 20174:57 pmRNSHolding(s) in Company
13th Jun 201710:15 amRNSHolding(s) in Company
6th Jun 20177:00 amRNSFinal Results
19th Apr 20177:00 amRNSTrading Update
13th Apr 201712:34 pmRNSDirector/PDMR Shareholding
12th Apr 20178:50 amRNSHolding(s) in Company
4th Apr 20174:35 pmRNSHolding(s) in Company
29th Mar 20178:00 amRNSExercise of share option
22nd Mar 20174:42 pmRNSHolding(s) in Company
6th Mar 20177:00 amRNSAppointment of M&A Director
2nd Mar 20179:48 amRNSHolding(s) in Company
27th Feb 20178:51 amRNSHolding(s) in Company
6th Feb 20178:54 amRNSHolding(s) in Company
26th Jan 20174:10 pmRNSHolding(s) in Company
25th Jan 201710:57 amRNSDirector/PDMR Shareholding
24th Jan 20174:27 pmRNSHolding(s) in Company
20th Jan 20174:06 pmRNSResult of Placing
20th Jan 20177:01 amRNSAcquisition & Proposed Placing
20th Jan 20177:00 amRNSTrading Update
16th Jan 201710:27 amRNSHolding(s) in Company
14th Dec 201612:03 pmRNSHolding(s) in Company
5th Dec 20169:36 amRNSHolding(s) in Company
29th Nov 20167:01 amRNSAppointment of Chairman Designate
29th Nov 20167:00 amRNSHalf-year Report
18th Oct 201611:52 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.